Bringing the fundamentals into focus…
Back to Contineum Therapeutics, Inc.
How Contineum Therapeutics, Inc. stacks up
CTNM · against 390 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #241 of 391 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score151 peers with a valuation score of 0–9, including CTNM · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -49.0% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -15.9% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -14.7% vs peer median 0.0%
Metric by metric
Position: dot = CTNM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTNM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 377 reported | -17.8% | -0.3% | 22% | 30% | |
| EBITDA yieldHigher is better · 394 reported | -49.0% | 2.0% | 9% | 50% | |
| Free cash flow yieldHigher is better · 188 reported | -14.7% | -9.3% | 39% | 20% | |
| Book yieldHigher is better · 386 reported | 65.8% | 50.4% | 64% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around CTNM| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 241 | 395M USD | 8 | 30 | |
| 241 | 296M USD | 8 | 26 | |
| 241 | 560M USD | 8 | 42 | |
| 241 | 475M USD | 8 | 22 | |
| 241 | 365M USD | 8 | 41 | |
| 241 | 357M USD | 8 | 32 | |
| 241 | 635M USD | 8 | 39 | |
| 241 | 539M USD | 8 | 33 | |
| 241 | 647M USD | 8 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score